ArticleQuantitative biology (Beijing, China)2025
Identifying early warning signals of cancer formation.
Article in Quantitative biology (Beijing, China), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identifying early warning signals of cancer formation.Quantitative biology (Beijing, China) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is increasingly clear that cancer is a complex systemic disease and one of the most fatal diseases in humans. Complex systems, including cancer, exhibit critical transitions in which the system abruptly shifts from one state to another. However, predicting these critical transitions is difficult as the system may show little change before the tipping point is reached. Models for predicting cancer are generally not accurate enough to reliably predict where these critical transitions will occur. Additionally, there is often a gap between theoretical results and clinical practice. To address these issues, we conducted a study using gastric cancer as a representative to reveal the tipping point of cancer and develop a feasible method for clinical monitoring. We used gene regulatory networks and a landscape framework to quantify the formation of gastric cancer. Since the dissipation cost of cancer cells is different from that of normal cells, we calculated the entropy product rate (EPR) and mean flux to quantify the thermodynamic cost and dynamical driving force in predicting critical transitions of cancer, which can serve as early warning signals. Both the EPR and mean flux change sharply near the point when the cancer state is about to emerge and/or the normal state is about to disappear. Moreover, the peak or sharp upward trends of the signals occur much earlier than critical slowdown and flickering frequency. These significant variations can be used as early warning signals for cancer. To further explore early warning signals in clinical and experimental trials, we calculated the difference in cross correlations (Δ
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.